Atyr Pharma, Stock Today
| ATYR Stock | 4.01 0.04 1.01% |
PerformanceOK
| Odds Of DistressQuite High
|
ATyr Pharma, is selling at 4.01 as of the 17th of March 2025; that is 1.01% up since the beginning of the trading day. The stock's lowest day price was 3.9. ATyr Pharma, has more than 62 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. ATyr Pharma, symbol was changed from LIFE on 5th of June 2024. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of May 2015 | Category Healthcare | Classification Health Care |
ATyr Pharma, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 75.8 M outstanding shares of which 4.35 M shares are presently shorted by private and institutional investors with about 1.47 trading days to cover. More on aTyr Pharma,
ATyr Stock Highlights
| Older Symbol | LIFE | ||||
| CEO President | MS MD | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsATyr Pharma, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ATyr Pharma,'s financial leverage. It provides some insight into what part of ATyr Pharma,'s total assets is financed by creditors.
| |||||
aTyr Pharma, (ATYR) is traded on NASDAQ Exchange in USA. It is located in 10240 Sorrento Valley Road, San Diego, CA, United States, 92121 and employs 56 people. aTyr Pharma, was previously known as LIFE Old and was traded on NASDAQ Exchange under the symbol LIFE. ATyr Pharma, is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 144.01 M. aTyr Pharma, conducts business under Biotechnology sector and is part of Health Care industry. The entity has 75.8 M outstanding shares of which 4.35 M shares are presently shorted by private and institutional investors with about 1.47 trading days to cover.
ATyr Pharma, generates negative cash flow from operations
Check ATyr Pharma, Probability Of Bankruptcy
Ownership AllocationATyr Pharma, holds a total of 75.8 Million outstanding shares. Over half of ATyr Pharma,'s outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ATyr Ownership Details
ATyr Pharma, Historical Income Statement
ATyr Stock Against Markets
ATyr Pharma, Corporate Management
| Danielle Campbell | VP Resource | Profile | |
| Jill CPA | Chief Officer | Profile | |
| Jill Broadfoot | Chief Officer | Profile | |
| Jayant MBA | Vice Operations | Profile | |
| Peter Villiger | Vice Development | Profile | |
| Nancy Krueger | General Secretary | Profile |
Already Invested in aTyr Pharma,?
The danger of trading aTyr Pharma, is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ATyr Pharma, is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ATyr Pharma,. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile aTyr Pharma, is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.